Outlook and developments
Microfluidics and Tumor DNA - Contribution of digital PCR
Research and innovation REF: RE241 V1
Outlook and developments
Microfluidics and Tumor DNA - Contribution of digital PCR

Authors : Philippe NIZARD, Aurélie KROL, Pierre LAURENT-PUIG, Valérie TALY

Publication date: February 10, 2015 | Lire en français

Logo Techniques de l'Ingenieur You do not have access to this resource.
Request your free trial access! Free trial

Already subscribed?

4. Outlook and developments

Coupled with recent developments in new-generation sequencers, the recent commercialization of digital PCR devices, and their increasingly frequent use, should have a major impact on our understanding of the complex processes involved in transforming a healthy cell into a cancerous one. Indeed, the molecular characterization of cancer cells and the correlation between the presence of certain mutations and resistance to conventional therapies have made it possible to develop new treatments, and to propose personalized treatments within the framework of targeted therapy. The growth of digital PCR will depend in part on the cost of these two technologies.

One of the advantages of digital PCR over qPCR is that qPCR requires calibration curves (which can vary from one laboratory to another and even between two experiments within the same laboratory) for quantification,...

You do not have access to this resource.
Logo Techniques de l'Ingenieur

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed?


Article included in this offer

"Technological innovations"

( 185 articles )

Complete knowledge base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

View offer details